Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • TEVA PHARMACEUTICAL INDS LTD Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 1.91 B 2.87 B 2.04 B 2.21 B 1.04 B
    Net Receivables 4.65 B 3.55 B 3.35 B 2.18 B 1.87 B
    Total Inventories 3.40 B 2.44 B 1.88 B 1.11 B 1.29 B
    Progress Payments & Others 30.00 M 30.00 M 26.00 M 38.00 M 37.90 M
    Prepaid Expenses
    Other Current Assets 1.47 B 998.00 M 364.00 M 0.00 0.00
    Current Assets Total 11.43 B 9.86 B 7.64 B 5.51 B 4.20 B
    Long Term Receivables 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 0.00
    Other Investments 425.00 M 632.00 M 596.00 M 410.60 M 843.60 M
    Property, Plant & Equipment Net 3.70 B 2.51 B 2.19 B 1.36 B 1.28 B
    Property, Plant & Equipment Gross 5.24 B 3.91 B 3.30 B 2.24 B 2.04 B
    Accumulated Depreciation 1.54 B 1.40 B 1.11 B 877.50 M 764.50 M
    Other Assets 16.91 B 10.36 B 10.02 B 3.11 B 3.31 B
    Deferred Charges 0.00 0.00 0.00 14.00 M 21.50 M
    Tangible Other Assets 30.00 M 34.00 M 0.00 0.00 0.00
    Intangible Other Assets 16.88 B 10.33 B 10.02 B 3.10 B 3.29 B
    Total Assets 32.46 B 23.37 B 20.45 B 10.39 B 9.63 B
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 2.91 B 1.84 B 742.00 M 375.50 M 560.40 M
    Accrued Payroll 254.00 M 129.60 M 120.90 M 86.50 M
    Income Taxes Payable 126.00 M 8.00 M 133.00 M 199.80 M 190.60 M
    Dividends Payable
    Other Current Liabilities 3.20 B 2.14 B 2.33 B 1.20 B 973.30 M
    Current Liabilities Total 8.48 B 5.37 B 4.07 B 2.26 B 2.20 B
    Long Term Debt 5.54 B 3.35 B 4.58 B 1.77 B 1.73 B
    Provision for Risks & Charges 182.00 M 149.00 M 152.00 M 84.40 M 87.60 M
    Deferred Taxes 1.28 B 413.00 M 469.00 M 219.30 M 212.30 M
    Deferred Income
    Deferred Tax Liability in Untaxed Reserves
    Other Liabilities 621.00 M 326.00 M 0.00 0.00 0.00
    Total Liabilities 16.10 B 9.61 B 9.28 B 4.34 B 4.23 B
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 60.00 M 36.00 M 35.00 M 8.00 M 10.90 M
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 16.30 B 13.72 B 11.14 B 6.04 B 5.39 B
    Common Stock 48.00 M 46.00 M 46.00 M 42.60 M 42.10 M
    Capital Surplus 11.50 B 8.25 B 7.88 B 3.39 B 3.04 B
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves -15.00 M -999,999.56 651.00 M 145.40 M 377.80 M
    Unappropriated (Free) Reserves
    Retained Earnings 5.29 B 5.04 B 3.40 B 3.08 B 2.17 B
    Equity in Untaxed Reserves 0.00 0.00 0.00 0.00 0.00
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) 408.00 M 1.42 B
    Unrealized Gain (Loss) on Marketable Securities -3.00 M -53.00 M 0.00 0.00 0.00
    Treasury Stock 924.00 M 982.00 M 830.00 M 617.10 M 237.40 M
    Total Liabilities & Shareholders Equity 32.46 B 23.37 B 20.45 B 10.39 B 9.63 B
    Common Shares Outstanding 850.72 M 768.42 M 758.00 M 618.60 M 611.40 M